Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Non Operating Income (2016 - 2025)

Lisata Therapeutics' Non Operating Income history spans 13 years, with the latest figure at -$16000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 45.45% year-over-year to -$16000.0; the TTM value through Dec 2025 reached $120000.0, up 146.69%, while the annual FY2025 figure was -$145000.0, 43.58% up from the prior year.
  • Non Operating Income reached -$16000.0 in Q4 2025 per LSTA's latest filing, up from -$18000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $703000.0 in Q3 2023 to a low of -$187000.0 in Q1 2024.
  • Average Non Operating Income over 3 years is $88500.0, with a median of -$12500.0 recorded in 2023.
  • Peak YoY movement for Non Operating Income: crashed 128.46% in 2024, then surged 186.1% in 2025.
  • A 3-year view of Non Operating Income shows it stood at -$11000.0 in 2023, then changed by 0.0% to -$11000.0 in 2024, then tumbled by 45.45% to -$16000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Non Operating Income are -$16000.0 (Q4 2025), -$18000.0 (Q3 2025), and -$7000.0 (Q2 2025).